Dana-Farber/Brigham and Women’s Adult Hematologic Oncology Treatment Center is one of the world’s largest and most respected treatment centers for patients with disorders of the blood or bone marrow as well as all types of cancers of the blood, including leukemia, lymphoma, multiple myeloma and Waldenström’s macroglobulinemia, as well as related disorders of the blood, such as aplastic anemia and myelodysplasia.
Because hematological disorders take many different forms, your care team includes experts with specialized knowledge in treating your condition. The Center also conducts a wide range of clinical research to evaluate potential new therapies.
Our physicians, radiologists, nurse practitioners, and other specialists work closely together to develop a treatment approach tailored to the unique characteristics of your disease and to accommodating your needs.
Our Contributions
Hematopathologists, molecular pathologists, and hematologic oncologists at Dana-Farber/Brigham and Women’s Cancer Center have developed and implemented a new genetic test that is improving and accelerating the diagnosis and management of patients with leukemias, myelodysplastic syndromes, and myeloproliferative disorders.
What to Expect
The Center is dedicated to providing patients with expert medical care during the entire course of treatment, from diagnosis, to the delivery of therapy, to follow-up care once treatment is completed.
